← All stocks

CUMBERLAND PHARMACEUTICALS INC

CPIX Net selling

CIK 0001087294 #4251 in the set updated 17 Sep 2026

Bought (120 mo)

$833.46K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$1.01M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$1.01M

81 of 81 sales

Net

−$179.33K

−$179.33K against sales at will

By person

17 insiders · 2,827 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Bernard Gordon R

Director

—

$694.66K (77)

−$694.66K

$0.00

−100.0%

Krogulski Kenneth

Director

$317.16K (593)

—

+$317.16K

302,338

$1.04M

+118.4%

Lawrence Thomas R

Director

—

$262.38K (3)

−$262.38K

$0.00

−100.0%

Galante Joseph C

Director

$138.11K (410)

—

+$138.11K

63,656

$219.61K

+315.8%

JACOBS JOEY A

Director

$106.71K (35)

—

+$106.71K

175,818

$606.57K

+31.8%

Cearnal Martin E

Sr VP/Chief Commercial Officer

$88.68K (174)

—

+$88.68K

163,473

$563.98K

+24.9%

KAZIMI A J

Chairman and CEO

$68.85K (470)

—

+$68.85K

5,695,310

$19.65M

−0.9%

Griggs Jonathan

Director

—

$55.76K (1)

−$55.76K

14,803

$51.07K

−16.9%

Young Caroline

Director

$41.61K (583)

—

+$41.61K

35,109

$121.13K

+838.0%

Jones James

Director

$38.42K (471)

—

+$38.42K

46,863

$161.68K

+319.6%

Bonner Michael

Chief Financial Officer

$24.99K (9)

—

+$24.99K

11,720

$40.43K

+31.2%

Hamm John M.

VP Chief Financial Officer

$8.93K (1)

—

+$8.93K

20,073

$69.25K

+569.1%

Pavliv Leo

SVP and Chief Development Off.

—

129,618

$447.18K

+21.7%

Herman James L

VP and Chief Compliance Office

—

38,255

$131.98K

−1.3%

Anthony Todd M.

Vice Pres Organizational Dev

—

16,328

$56.33K

−4.8%

Brown Martin S JR

Director

—

10,300

$35.54K

+87.3%

Bitterman Chris T.

Vice Pres Sales & Marketing

—

4,683

$16.16K

−11.2%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 334

Amendments (4/A) skipped 6

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 81

Transactions with no price 0

Shares from compensation/vesting 1,403,600

Sales filed before the plan box existed 81

History held since 18 Nov 2016